Tag: Sophiris Bio
Tiny Biotech Stock Set To Go Higher With Cure For Something Other Than Cancer
Traditionally, biotech investors are handsomely rewarded for owning shares of companies working on treatments for cancer, once approved by the FDA. Yet there is one company poised to skyrocket on a drug that cures a non-cancerous ailment. Sophiris Bio (SPHS, $1.67) is knocking on the door of an effective treatment for enlarged prostate. Located in […]
